Risperidone appears safe in patients with antipsychotic-induced blood dyscrasias

Int Clin Psychopharmacol. 1996 Mar;11(1):53-4. doi: 10.1097/00004850-199603000-00007.

Abstract

Two cases are reported who developed blood dyscrasias, involving neutropenia and thrombocytopenia respectively, after treatment with phenothiazine and butyrophenone antipsychotics. A subsequent good therapeutic response was obtained with risperidone. It is suggested that risperidone may be considered as an alternative when blood dyscrasias occur with classic antipsychotics.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Butyrophenones
  • Female
  • Humans
  • Male
  • Neutropenia / chemically induced*
  • Neutropenia / prevention & control
  • Phenothiazines
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced*
  • Purpura, Thrombocytopenic, Idiopathic / prevention & control
  • Risperidone / therapeutic use*
  • Schizophrenia / drug therapy

Substances

  • Antipsychotic Agents
  • Butyrophenones
  • Phenothiazines
  • Risperidone